Storgard Chris Insider Trades

Insider Trading History

Track insider trading activity for Storgard Chris. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Design Therapeutics
Design Therapeutics DSGN
Chief Medical Officer
Holding Value $2.61M 250,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.28M 250,000 shares
$9.10
$10.44
Design Therapeutics
Design Therapeutics DSGN
Chief Medical Officer
Holding Value $4.18M 400,000 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 400,000 shares
$4.71
$10.44
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $413k 186,000 shares
Last Trade
Jan 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 186,000 shares
$6.55
$2.22
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $333k 150,000 shares
Last Trade
Jan 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 150,000 shares
$2.73
$2.22
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $83.5k 37,593 shares
Last Trade
Nov 23, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$124k 37,593 shares
$3.29
$2.22
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $444k 200,000 shares
Last Trade
May 16, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 209,090 shares
$1.47
$2.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up